The DOI matches its Crossref record; 229 of the 229 references it cites were found in a registry or an index.
N-Methyl-d-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–229 of 229
Huntington??s disease: present treatments and future therapeutic modalities
Bonelli, R. M., Wenning, G. K., & Kapfhammer, H. (2004) · International Clinical Psychopharmacology · doi:10.1097/00004850-200403000-00001 · Cited by 92
Picconi, B., Passino, E., Sgobio, C., Bonsi, P., Barone, I., Ghiglieri, V., Pisani, A., Bernardi, G., Ammassari‐Teule, M., & Calabresi, P. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.10.009 · Cited by 90
Increased Vulnerability to 3‐Nitropropionic Acid in an Animal Model of Huntington's Disease
Bogdanov, M. B., Ferrante, R. J., Kuemmerle, S., Klivènyi, P., & Beal, M. F. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71062642.x · Cited by 88
Creatine therapy for Huntington’s disease: Clinical and MRS findings in a 1-year pilot study
Tabrizi, S. J., Blamire, A. M., Manners, D. N., Rajagopalan, B., Styles, P., Schapira, A. H. V., & Warner, T. T. (2003) · Neurology · doi:10.1212/01.wnl.0000070186.97463.a7 · Cited by 87
Minocycline for Huntington’s disease: An open label study
Bonelli, R. M., Heuberger, C., & Reisecker, F. (2003) · Neurology · doi:10.1212/01.wnl.0000049936.85487.7a · Cited by 87
Altered Cortical Glutamate Receptor Function in the R6/2 Model of Huntington's Disease
André, V. M., Cepeda, C., Venegas, Á., Gomez, Y., & Levine, M. S. (2005) · Journal of Neurophysiology · doi:10.1152/jn.01118.2005 · Cited by 78
Reddy, P. H., Charles, V., Williams, M., Miller, G., Whetsell, W. O., & Tagle, D. A. (1999) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.1999.0456 · Cited by 73
Multiplicity of glutamate receptor subunits in single striatal neurons: an RNA amplification study.
Ghasemzadeh, M. B., Sharma, S., Surmeier, D. J., Eberwine, J. H., & Chesselet, M. ‐. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09077-7 · Cited by 72
Schwarcz, R. M., Bennett, J. P., & Coyle, J. T. (1977) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1977.tb10641.x · Cited by 64
Orlando, L. R., Alsdorf, S. A., Penney, J. B., & Young, A. B. (2001) · Experimental Neurology · doi:10.1006/exnr.2000.7542 · Cited by 62
Cognitive Manifestations of Huntington Disease in Relation to Genetic Structure and Clinical Onset
Jason, G. W., Suchowersky, O., Pajurkova, E. M., Graham, L. M., Klimek, M. L., Garber, A. T., & Poirier-Heine, D. (1997) · Archives of Neurology · doi:10.1001/archneur.1997.00550210019008 · Cited by 61
Tang, T., Tu, H., Orban, P. C., Chan, E. Y. W., Hayden, M. R., & Борисович, Б. И. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03633.x · Cited by 58
Pharmaceutical, cellular and genetic therapies for Huntington's disease
Handley, O., Naji, J. J., Dunnett, S. B., & Rosser, A. (2005) · Clinical Science · doi:10.1042/cs20050148 · Cited by 55
Petersén, Å., Chase, K. O., Puschban, Z., DiFiglia, M., Brundin, P., & D, N. A. M. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.7885 · Cited by 52
Expression of Mutant Huntingtin Blocks Exocytosis in PC12 Cells by Depletion of Complexin II
Edwardson, J. M., Wang, C., Gong, B., Wyttenbach, A., Bai, J., Jackson, M. B., Chapman, E. R., & Morton, A. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304615200 · Cited by 52
Ali, N. J., & Levine, M. S. (2006) · Developmental Neuroscience · doi:10.1159/000091921 · Cited by 49
Christie, J. M., Jane, D. E., & Monaghan, D. T. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35403-5 · Cited by 47
Cognitive, behavioral, and motor effects of the NMDA antagonist ketamine in Huntington's disease
Murman, D. L., Giordani, B., Mellow, A. M., Johanns, J. R., Little, R. J. A., Hariharan, M., & Foster, N. L. (1997) · Neurology · doi:10.1212/wnl.49.1.153 · Cited by 46
Connecting the dots in Huntington's disease with protein interaction networks.
Giorgini, F., & Muchowski, P. J. (2005) · Genome biology · doi:10.1186/gb-2005-6-3-210 · Cited by 45
Neuronal vulnerability in mouse models of Huntington's disease: Membrane channel protein changes
Ariano, M. A., Wagle, N. A., & Grissell, A. E. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20492 · Cited by 42
Impaired learning-dependent cortical plasticity in Huntington's disease transgenic mice
Cybulska-Kłosowicz, A., Mazarakis, N. K., VanDellen, A., Blakemore, C. B., Hannan, A. J., & Kossut, M. M. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.08.009 · Cited by 40
Society for Neuroscience--31st annual meeting.
Kibble, A., & Durrance, A. (2001) · PubMed · Cited by 40
Cramer, H., Jm, W., & Renaud, B. (1984) · PubMed · Cited by 39
Cepeda, C., Itri, J. N., Flores‐Hernández, J., Hurst, R. S., Calvert, C. R., & Levine, M. S. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01783.x · Cited by 38
Dalbem, A., Silveira, C. V., Pedroso, M. F., Breda, R. V., Baes, C. V. W., Bartmann, A. P., & da Costa, J. C. (2005) · Brain Research · doi:10.1016/j.brainres.2005.04.030 · Cited by 26
Molecular Mechanisms of Synaptogenesis
Dityatev, A. E., & El-Husseini, A. (2006) · Springer eBooks · doi:10.1007/978-0-387-32562-0 · Cited by 24
Wang, Y. T., Pak, Y., & Salter, M. W. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90732-z · Cited by 14
Synaptic Abnormalities Associated with Huntington’s Disease
Milnerwood, A. J., & Raymond, L. A. (2006) · Springer eBooks · doi:10.1007/978-0-387-32562-0_32 · Cited by 8
Self-citationIncreased activity of surviving locus ceruleus neurons in Alzheimer's disease
Moser (1999) · Pure Amsterdam UMC · doi:10.1002/1531-8249(199901)45:1
Cited by
Synaptic Energy Use and Supply
Harris, J. J., Jolivet, R., & Attwell, D. (2012) · Neuron · doi:10.1016/j.neuron.2012.08.019 · Cited by 1,747
Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders
Hardingham, G. E., & Bading, H. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2911 · Cited by 1,644
Dong, X.-X., Wang, Y., & Qin, Z.-H. (2009) · Acta Pharmacologica Sinica · doi:10.1038/aps.2009.24 · Cited by 1,297
Striatal Plasticity and Basal Ganglia Circuit Function
Kreitzer, A. C., & Malenka, R. C. (2008) · Neuron · doi:10.1016/j.neuron.2008.11.005 · Cited by 1,017
Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders
Sanacora, G., Zarate, C. A., Krystal, J. H., & Manji, H. K. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2462 · Cited by 894
Metadata
- Authors
- FAN, M., & RAYMOND, L.
- Venue
- Progress in Neurobiology
- Publisher
- Elsevier BV
- Published
- 2007-04
- Volume
- 81
- Issue
- 5-6
- Pages
- 272-293
- ISSN
- 0301-0082 (ISSN-L)
- OpenAlex
- W1998237974
- Cited by
- 413
- References
- 229
- FWCI
- 7.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.